Ausgabe 7/2004
Inhalt (10 Artikel)
CD44v6: a target for antibody-based cancer therapy
Karl-Heinz Heider, Hartmut Kuthan, Gerd Stehle, Gerd Munzert
α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells
Lalitha V. Ramanathapuram, James J. Kobie, David Bearss, Claire M. Payne, Katrina T. Trevor, Emmanuel T. Akporiaye
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes
Frank Neumann, Claudia Wagner, Boris Kubuschok, Stefan Stevanovic, Hans-Georg Rammensee, Michael Pfreundschuh
Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis
Cecilia Melani, Antonella Stoppacciaro, Chiara Foroni, Federica Felicetti, Alessandra Caré, Mario P. Colombo
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells
Kenji Matsuda, Takuya Tsunoda, Hajime Tanaka, Yasukazu Umano, Hiroshi Tanimura, Ikuei Nukaya, Kazutoh Takesako, Hiroki Yamaue
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone
Hiroko Nakajima, Kotomi Kawasaki, Yoshihiro Oka, Akihiro Tsuboi, Manabu Kawakami, Kazuhiro Ikegame, Yoshihiko Hoshida, Fumihiro Fujiki, Akiko Nakano, Tomoki Masuda, Fei Wu, Yuki Taniguchi, Satoshi Yoshihara, Olga A. Elisseeva, Yusuke Oji, Hiroyasu Ogawa, Ichiro Azuma, Ichiro Kawase, Katsuyuki Aozasa, Haruo Sugiyama
T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent
Michael Gruen, Kurt Bommert, Ralf C. Bargou
Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
Inge Marie Svane, Anders E. Pedersen, Hans E. Johnsen, Dorte Nielsen, Claus Kamby, Eva Gaarsdal, Kirsten Nikolajsen, Søren Buus, Mogens H. Claesson
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
Sophie Hallez, Philippe Simon, Frédéric Maudoux, Jean Doyen, Jean-Christophe Noël, Aude Beliard, Xavier Capelle, Frédéric Buxant, Isabelle Fayt, Anne-Cécile Lagrost, Pascale Hubert, Colette Gerday, Arsène Burny, Jacques Boniver, Jean-Michel Foidart, Philippe Delvenne, Nathalie Jacobs
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate
R. Vilella, D. Benítez, J. Milà, M. Lozano, R. Vilana, J. Pomes, X. Tomas, J. Costa, A. Vilalta, J. Malvehy, S. Puig, B. Mellado, R. Martí, T. Castel